Medical case reports suggest that cannabinoids extracted from Cannabis sativa have
therapeutic effects; however, the therapeutic employment is limited due to the psychotropic …

Pain is a very frequent symptom with influence on the quality of life in Parkinson's disease
(PD), but is still underdiagnosed and commonly treated only unsystematically. Pain etiology …

Parkinson's disease (PD) and l-DOPA-induced dyskinesia (LID) are motor disorders with
significant impact on the patient's quality of life. Unfortunately, pharmacological treatments …

Background: Little is known about the patients' view on treatment with medical cannabis
(MC) for Parkinson's disease (PD). Objective: To assess the PD community's perception of …

Abstract Purpose of Review Older adults currently represent the fastest growing
demographic of cannabis users, yet few studies have investigated the effects of cannabis …

Cannabis and cannabinoids are often considered in the treatment of Parkinson's Disease
(PD). The purpose of this paper was to perform a systematic review of the available data on …

Current pharmacotherapy of Parkinson's disease (PD) is symptomatic and palliative, with
levodopa/carbidopa therapy remaining the prime treatment, and nevertheless, being unable …

Objectives To evaluate medical marijuana patients' perceptions of therapeutic benefits for
self-reported medical conditions. Design The study was a concurrent mixed methods study …

Parkinson's disease (PD) is featured by movement impairments, including tremors,
bradykinesia, muscle stiffness, and imbalance. PD is also associated with many non-motor …

Parkinson's disease (PD) is the second most frequent neurodegenerative disease and
currently represents a clear unmet medical need. Therefore, novel preventive and …